Editorial: Challenges in developing new multiple sclerosis therapies

Frohman, E.M. , Racke, M.K. and Raine, C.S. (2006) Multiple sclerosis: The plaque and its pathogenesis . New Engl J Med 354: 942-955.

Hauser, S.L. , Waubant, E. , Arnold, D.L. , Vollmer, T. , Antel, J. , Fox, R.J. et al. (2008) B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 358: 676-688.

Khalili, K. , White, M.K. , Lublin, F. , Ferante, P. and Berger, J.R. (2007) Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology 68: 985-990.

Polman, C.H. , Reingold, S.C. , Edan, G. , Filippi, M. , Hartung, H.P. , Kappos, L. et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the `McDonald Criteria'. Ann Neurol 58: 840-846.

Richert, N.D. , Ostuni, J.L. , Bash, C.N. , Duyn, J.H. , McFarland, H.F. and Frank, J.A. (1998) Serial whole-brain magnetization transfer imaging in patients with relapsing remitting multiple sclerosis at baseline and during treatment with interferon-beta1b. Am J Neuroradiol 19: 1705-1713.

Rudick, R. , Fisher, E. , Lee, J.C. , Simon, J. and Jacobs, L. (1999) Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Neurology 53: 1698-1704.

Zivadinov, R. , Reder, A.T. , Filippi, M. , Minagar, A. , Stüve, O. and Lassmann, H. (2008) Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. Neurology 71: 136-144.